About Issar Pharmaceuticals Private Limited
Data last updated:
Issar Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 October 1995.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1995PTC022131. The company has 3 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹55 Cr and a paid-up capital of ₹55 Cr. It was led by directors Rama Krishna Reddy Isanaka and Isanaka Shaalini.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.31 Cr. For the same year it recorded a net loss of ₹71.46 Lakh (net margin -8.6%) and EBITDA of ₹2.83 Cr (EBITDA margin 34%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 12% over five years.
The company is associated with 1 brand: Issar Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹28.25 Cr on record. Court records list 27 cases involving the company, including 15 filed by the company and 12 filed against it; 4 cases are pending. The company has 2 deals on record (1 acquisition, 1 secondary share transfer); the latest was in May 2016. Its 4 peer companies in the Pharma industry (API Manufacturers, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Ria Biosciences Private Limited with revenue of ₹8.34 Cr.
The last known website on record is issar.co.in.
Company details
CIN history
Issar Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP1995PTC022131. The current CIN is U24239TG1995PTC022131, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1995PTC022131 | Current |
| U24239AP1995PTC022131 | Previous |
Contact details
Issar Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is issar.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH. No. 8 – 2 – 334 Serene Chambers Flat No. W – 301 & 302 Road No.5 Banja, Ra Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Issar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Issar Pharmaceuticals operates one associated brand: Issar Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Peptide-based therapeutics are developed for treating multiple diseases. | issar.co.in |
Business activity
The main business activity of Issar Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Issar Pharmaceuticals Private Limited
FY 2022 filings availableIssar Pharmaceuticals Private Limited reported revenue of ₹8.31 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹71.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34% | ||||
| Net Profit Margin | -8.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Issar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Krishna Reddy Isanaka Also directs: Relief Art Gallery LLP, Issar Pharmaceuticals LLP | Director | 02 Sep 1999 | 27 Years 1 Months | As last reported |
| Isanaka Shaalini Also directs: Relief Art Gallery LLP, Issar Pharmaceuticals LLP | Director | 12 Apr 2016 | 10 Years 6 Months | As last reported |
Peer comparison
Issar Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ria Biosciences Private Limited | ₹8.34 Cr (FY 2025) | 66.0% | Delhi, India | |||
| Sterlife Biotech Private Limited | ₹8.32 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India | |||
| Almet Lifesciences Private Limited | ₹8.32 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Issar Pharmaceuticals Private Limitedthis company | ₹8.31 Cr (FY 2024) | -₹71.46 Lakh | -8.6% | Hyderabad, Telangana, India | ||
| Arogya Formulations Private Limited | ₹8.29 Cr (FY 2024) | 45.0% | Delhi, India |
To see the full peer comparison of Issar Pharmaceuticals Private Limited, buy the company report.
Auditor
Issar Pharmaceuticals Private Limited is audited by REDDY A V & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| REDDY A V & CO | FY 2022 | 003256S |
Shareholding
The shareholding of Issar Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Issar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Jun 2011 | 10294014 | State Bank of India | ₹24.2 Cr | Satisfied | |
| 05 Jun 2006 | 10006700 | Uti Bank Limited | ₹1 Cr | Satisfied | |
| 12 Nov 2005 | 90259219 | The Karnataka Bank Limited | ₹25 Lakh | Satisfied | |
| 12 Nov 2005 | 80005994 | The Karnataka Bank Limited | ₹- | Satisfied | |
| 19 Nov 2003 | 90117878 | Karnataka Bank | ₹5.3 Lakh | Satisfied |
To see the full charge records of Issar Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Issar Pharmaceuticals Private Limited has 2 deals on record (1 acquisition, 1 secondary share transfer); the latest was in May 2016.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2016 | Acquisition | Undisclosed | Buyer: Zydus Lifesciences Limited Seller: Issar Pharmaceuticals Private Limited |
| Sep 2006 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Issar Pharmaceuticals Private Limited has 27 court cases on record: 15 filed by Issar Pharmaceuticals, 12 filed against it. 4 cases are pending and 23 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 6 | 3 |
| District courts | 9 | 5 | 1 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Cri.Appeal) | Filed against the company by Ms Nilsan Nishotech System Pvt Ltd Through Its Director Mr Sanjay Chimanlal Badani | Pending |
| High Court | Court case (CARBP) | Filed against the company by Alkem Laboratories Ltd | Pending |
| High Court | Interim or miscellaneous application | Filed against the company by Alkem Laboratories Ltd | Disposed |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against Alkem Laboratories Ltd. | Disposed |
| Bombay High Court | Court case (CARAP) | Filed by the company against Alkem Laboratories Ltd. | Disposed |
To see the full case history of Issar Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Issar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Issar Pharmaceuticals has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Issar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Issar Pharmaceuticals Private Limited has 10 board changes on record since 1999: 2 appointments and 8 cessations. The latest: Sheila Isanaka ceased to be Director on 01 Oct 2022.
13 earlier events are in the company report.
Frequently asked questions
Issar Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Issar Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 31 October 1995 and is registered under CIN U24239TG1995PTC022131. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Issar Pharmaceuticals is U24239TG1995PTC022131. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Issar Pharmaceuticals had 2 directors:
- Rama Krishna Reddy Isanaka - Director
- Isanaka Shaalini - Director
Issar Pharmaceuticals was incorporated on 31 October 1995. It is registered with the Registrar of Companies, Hyderabad.
Issar Pharmaceuticals can be reached through the website issar.co.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Issar Pharmaceuticals is at H. No. 8 – 2 – 334 Serene Chambers Flat No. W – 301 & 302 Road No.5 Banja, Ra Hills, Hyderabad, Telangana, India – 500034.
The latest financial statements of Issar Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
No. Issar Pharmaceuticals has 3 GST registrations on record and all of them are cancelled or inactive.
Issar Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
Issar Pharmaceuticals has 2 deals on record (1 acquisition, 1 secondary share transfer); the latest was in May 2016.